Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2

被引:57
作者
Zhao, Hailin [1 ]
Mitchell, Sian [1 ]
Ciechanowicz, Sarah [1 ]
Savage, Sinead [1 ]
Wang, Tianlong [2 ]
Ji, Xunming [3 ]
Ma, Daqing [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sect Anaesthet Pain Med & Intens Care, Fac Med,Dept Surg & Canc, London, England
[2] Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China
[3] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China
关键词
Argon; Perinatal hypoxic-ischaemic encephalopathy; Nrf2; KINASE/AKT PATHWAY; OXIDATIVE STRESS; NOBLE-GASES; NEUROPROTECTION; NRF2; ENCEPHALOPATHY; ASPHYXIA; CELLS; XENON; MECHANISMS;
D O I
10.18632/oncotarget.8241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Perinatal hypoxic ischaemic encephalopathy (HIE) has a high mortality rate with neuropsychological impairment. This study investigated the neuroprotective effects of argon against neonatal hypoxic-ischaemic brain injury. In vitro cortical neuronal cell cultures derived from rat foetuses were subjected to an oxygen and glucose deprivation (OGD) challenge for 90 minutes and then exposed to 70% argon or nitrogen with 5% carbon dioxide and balanced with oxygen for 2 hours. In vivo, seven-day-old rats were subjected to unilateral common carotid artery ligation followed by hypoxic (8% oxygen balanced with nitrogen) insult for 90 minutes. They were exposed to 70% argon or nitrogen balanced with oxygen for 2 hours. In vitro, argon treatment of cortical neuronal cultures resulted in a significant increase of p-mTOR and Nuclear factor (erythroid-derived 2)-like 2(Nrf2) and protection against OGD challenge. Inhibition of m-TOR through Rapamycin or Nrf2 through siRNA abolished argon-mediated cyto-protection. In vivo, argon exposure significantly enhanced Nrf2 and its down-stream effector NAD(P)H Dehydrogenase, Quinone 1(NQO1) and superoxide dismutase 1(SOD1). Oxidative stress, neuroinflammation and neuronal cell death were significantly decreased and brain infarction was markedly reduced. Blocking PI-3K through wortmannin or ERK1/2 through U0126 attenuated argon-mediated neuroprotection. These data provide a new molecular mechanism for the potential application of Argon as a neuroprotectant in HIE.
引用
收藏
页码:25640 / 25651
页数:12
相关论文
共 42 条
[11]   Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury [J].
Fan, Xiyong ;
Kavelaars, Annemieke ;
Heijnen, Cobi J. ;
Groenendaal, Floris ;
van Bel, Frank .
CURRENT NEUROPHARMACOLOGY, 2010, 8 (04) :324-334
[12]   Hypoxic-Ischemic Encephalopathy in the Term Infant [J].
Fatemi, All ;
Wilson, Mary Ann ;
Johnston, Michael V. .
CLINICS IN PERINATOLOGY, 2009, 36 (04) :835-+
[13]   Mechanisms of Cell Protection by Heme Oxygenase-1 [J].
Gozzelino, Raffaella ;
Jeney, Viktoria ;
Soares, Miguel P. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 :323-354
[14]   Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis [J].
Hota, Kalpana Barhwal ;
Hota, Sunil Kumar ;
Chaurasia, Om Prakash ;
Singh, Shashi Bala .
HIPPOCAMPUS, 2012, 22 (04) :723-736
[15]   The transcription factor Nrf2 is a therapeutic target against brain inflammation [J].
Innamorato, Nadia G. ;
Rojo, Ana I. ;
Garcia-Yaguee, Angel J. ;
Yamamoto, Masayuki ;
de Ceballos, Maria L. ;
Cuadrado, Antonio .
JOURNAL OF IMMUNOLOGY, 2008, 181 (01) :680-689
[16]   Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury [J].
Jawad, Noorulhuda ;
Rizvi, Maleeha ;
Gua, Jianteng ;
Adeyi, Olar ;
Tao, Guocai ;
Maze, Mervyn ;
Ma, Daqing .
NEUROSCIENCE LETTERS, 2009, 460 (03) :232-236
[17]   Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling [J].
Jones, NM ;
Bergeron, M .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (01) :157-167
[18]   The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer [J].
Kansanen, Emilia ;
Kuosmanen, Suvi M. ;
Leinonen, Hanna ;
Levonen, Anna-Liisa .
REDOX BIOLOGY, 2013, 1 (01) :45-49
[19]   Animal research: Reporting in vivo experiments: The ARRIVE guidelines [J].
Kilkenny, Carol ;
Browne, William ;
Cuthill, Innes C. ;
Emerson, Michael ;
Altman, Douglas G. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (07) :1577-1579
[20]   Nrf2, a multi-organ protector? [J].
Lee, JM ;
Li, J ;
Johnson, DA ;
Stein, TD ;
Kraft, AD ;
Calkins, MJ ;
Jakel, RJ ;
Johnson, JA .
FASEB JOURNAL, 2005, 19 (09) :1061-1066